PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Código QR

PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

The prognostic value of tumor necrosis factor-alfa (TNFα), a pro-inflammatory cytokine was studied in 140 patients with a newly diagnosed chronic lymphocytic leukemia (CLL). TNFα contents in blood serum was determined using ELISA method. A significant increase of serum TNFα was shown in patients wit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	E. N. Zotina, T. P. Zagoskina, V. I. Shardakov, A. V. Yovdy, G. A. Zaitseva
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2016
Materias:	chronic lymphocytic leukemia cytokines tumor necrosis factor-alpha prognosis overall survival Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/21ce1f035d114e6182dde3c3631951f2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB
por: M. N Khorobrykh, et al.
Publicado: (2014)

An unusual presentation of chronic lymphocytic leukemia
por: Dinesh Atwal, et al.
Publicado: (2017)

An unusual presentation of chronic lymphocytic leukemia
por: Dinesh Atwal, et al.
Publicado: (2017)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
por: O. V. Smirnova, et al.
Publicado: (2014)

FEATURES OF IMMUNOCOMPETENT CELLS IN THE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT PRIMARY DIAGNOSIS
por: N. V. Isaeva, et al.
Publicado: (2016)

Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
por: Fusun Gediz, et al.
Publicado: (2021)

Chronic lymphocytic leukemia in general practice
por: Đurović Ljiljana P.
Publicado: (2021)

Functional characterization of rs2229094 (T>C) polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: the Retina 4 project
por: Pastor-Idoate S, et al.
Publicado: (2017)

Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
por: Seiter K, et al.
Publicado: (2015)

Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
por: Alberto Fresa, et al.
Publicado: (2021)

EVALUATION OF FCR THERAPY EFFICACY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BASED ON IMMUNOGENETIC CRITERIA
por: E. L. Nazarova, et al.
Publicado: (2018)

The Correlation of initial hematological feature with advanced stage in Chronic Lymphocytic Leukemia in Kurdistan Region of Iraq
por: tavan Ismeil
Publicado: (2021)

Chronic lymphocytic leukemia/small lymphocytic lymphoma
por: E. A. Nikitin, et al.
Publicado: (2020)

Prognostic impact of microsatellite instability in gastric cancer
por: Cesar Zepeda-Najar, et al.
Publicado: (2021)

Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy
por: Sayaka Kiso, et al.
Publicado: (2021)

Hialohifomicosis invasiva hepatoesplénica.: Comunicación de un caso
por: Pilleux C,Lilian, et al.
Publicado: (2000)

Immunohistochemistry for Thymidine Kinase-1 (TK1): A Potential Tool for the Prognostic Stratification of Breast Cancer Patients
por: Giuseppe Nicolò Fanelli, et al.
Publicado: (2021)

Expression of tumor necrosis factor-alpha receptor 2 and interleukin-1 in middle ear cholesteatoma
por: Vranješ Dalibor, et al.
Publicado: (2021)

Association of Tumor Necrosis Factor Alpha (TNF-α)-1031 Polymorphism with Chronic Infection of Patients with HCV
por: SH Baradaran Ghavami,, et al.
Publicado: (2012)

The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
por: Mojdeh Soltani, et al.
Publicado: (2021)

Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
por: Ziyi Liu, et al.
Publicado: (2021)

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
por: Madanat YF, et al.
Publicado: (2016)

Papel de los polimorfismos -238 y -308 del promotor del factor de necrosis tumoral alfa en la patogenia y respuesta al tratamiento anti- factor de necrosis tumoral alfa en artritis reumatoide
por: Llanos M,Carolina, et al.
Publicado: (2005)

Prognostic Significance of Estrogen Receptor Alpha in Oral Squamous Cell Carcinoma
por: Christian Doll, et al.
Publicado: (2021)

ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
por: Irina V. Poddubnaya, et al.
Publicado: (2020)

LEVELS OF TUMOR NECROSIS FACTOR ALPHA IN PATIENTS WITH ISCHEMIC STROKE
por: I. A. Prilutskaya, et al.
Publicado: (2019)

O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers
por: David E. Spaner, et al.
Publicado: (2021)

ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia
por: Tatiana E. Bialik, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
por: Qian X, et al.
Publicado: (2021)

CORRELATION OF TRISOMY 12 WITH CLINICAL FEATURES AND OTHER LABORTARY PARAMETERS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA
por: Ali Ahmed, et al.
Publicado: (2021)

Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia
por: Federica Frezzato, et al.
Publicado: (2021)

Construction of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in acute myeloid leukemia
por: Xianbo Huang, et al.
Publicado: (2021)

Acalabrutinib in the treatment of chronic lymphocytic leukemia: a review of recent evidence
por: Andrei A. Petrenko, et al.
Publicado: (2021)

Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
por: Kristyna Zavacka, et al.
Publicado: (2021)

ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
por: E. V. Voronina, et al.
Publicado: (2018)

El polimorfismo genético del factor de necrosis tumoral alfa como factor de riesgo en patología
por: Aguillón G,Juan C, et al.
Publicado: (2002)

High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
por: Elalouf O, et al.
Publicado: (2021)

El comportamiento del factor de necrosis tumoral alfa e interleucina 6 en lesiones de vías biliares postcolecistectomía
por: MIRANDA-DÍAZ,ALEJANDRA G, et al.
Publicado: (2010)

Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis
por: Ping Zeng, et al.
Publicado: (2021)

Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases
por: Zhiyang Zhang, et al.
Publicado: (2021)